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SUMMARY
The inflammatory response to ozone in atopic asthma suggests that soluble mediators of inflammation
are released in response to oxidant stress. Antioxidants may alleviate additional oxidative stress associated with photochemical oxidant pollution. This study investigates the impact of antioxidant supplementation on the nasal inflammatory response to ozone exposure in atopic asthmatic children. We
conducted a randomized trial using a double-blinded design. Children with asthma (n = 117), residents
of Mexico City, were given randomly a daily supplement of vitamins (50 mg/day of vitamin E and
250 mg/day of vitamin C) or placebo. Nasal lavages were performed three times during the 4-month
follow-up and analysed for content of interleukin-6 (IL-6), IL-8, uric acid and glutathione (GSx). IL-6
levels in the nasal lavage were increased significantly in the placebo group after ozone exposure while
no increase was observed in the supplement group. The difference in response to ozone exposure
between the two groups was significant (P = 0·02). Results were similar for IL-8, but with no significant
difference between the groups (P = 0·12). GSx decreased significantly in both groups. Uric acid
decreased slightly in the placebo group. Our data suggest that vitamin C and E supplementation above
the minimum dietary requirement in asthmatic children with a low intake of vitamin E might provide
some protection against the nasal acute inflammatory response to ozone.
Keywords

antioxidants

childhood asthma

cytokines/ interleukins

INTRODUCTION
Exposure to oxidants from different sources has been related to
asthma incidence, increased frequency of respiratory symptoms
and bronchial response [1,2]. In controlled human studies, mild
atopic asthmatics exposed to short-term peak ambient levels of
ozone experience an acute inflammatory response in the lower
airways and a decrement in lung function [3,4]. Recent studies
examining the inflammatory response in bronchoalveolar lavage
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(BAL) fluid and bronchial wash in mild atopic asthmatics have
shown that short-term exposure to ozone induces polymorphonuclear leucocytes (PMNL) influx in the lower airway, paralleled by
the release of soluble mediators of inflammation including
albumin, total protein, myeloperoxidase (MPO), lactate deshydrogenase and cytokines [including interleukin-8 (IL-8) and
granulocyte-macrophage colony-stimulating factor (GM-CSF)]
and eosinophil cationic proteins [5,6].
Although the role of reactive oxygen species (ROS) in the
inflammatory and immunological cascade characteristics of
asthma is not well understood, antioxidants could prove useful as
an adjuvant treatment for asthma, particularly in subjects exposed
to additional oxidative stress associated with photochemical oxidant pollution [3,7]. Both experimental and epidemiological studies have suggested that antioxidant supplementation could
modulate the acute change in lung functions observed among
people exposed to photo-oxidants [8,9]. To date only one controlled human study conducted in healthy volunteers has investigated the role of dietary antioxidants on the inflammatory
responses of the lung to ozone exposure [9].
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The Metropolitan Area of Mexico City experiences significant
air pollution problems related in particular to high ozone levels.
We have reported recently that supplementation with antioxidants modulates the impact of ozone exposure on small airways of
moderate to severe asthmatic children residing in Mexico City
[10]. In this paper we investigated the impact of antioxidant supplementation on the inflammatory response of the airways due to
ozone exposure in the same asthmatic population.

MATERIALS AND METHODS
Study population
The study design has been presented elsewhere [10]. Briefly,
children were recruited through the allergy clinic of the Hospital Infantil Federico Gomez. All children were followed for
their asthma at this clinic and were classified according to the
NLBI [11] as intermittent, mild persistent, moderate persistent
or severe. One hundred and sixty children were recruited and
followed for 12 weeks, divided into groups of 40 and treated in
a sequential manner. Parents were asked to sign a consent
form allowing their child to participate. The protocol was
reviewed and approved by the ethical committees of the Hospital Infantil de Mexico and the Instituto Nacional de Salud Publica, Mexico.
Children were assigned randomly to received either supplement (vitamin C; 250 mg/day and vitamin E 50 mg/day), or placebo in a doubled-blinded manner, informing neither the health
personnel at the clinic or the patients of the assignment code. Placebo and supplement were presented in similar pills (provided by
Roche Laboratory). During the 12 weeks of follow-up, children
performed two spirometric tests per week. Blood samples were
obtained at baseline, after 6 weeks of follow-up and at the end of
the follow-up (12 weeks) to check compliance with the supplementation. Nasal lavages were obtained from only 120 children
(2nd, 3rd, 4th groups) at baseline and at 6 and 12 weeks of the
follow-up. Two participants did not complete the follow-up
because the mother found it too cumbersome to visit the asthma
clinic twice a week and nasal lavage samples could not be
obtained from one child. These three children were excluded
from the analysis
Exposure assessment
We obtained measurements of particulates (with a mass median
diameter of less than 10 mm, PM10), ambient ozone and climatic
variables (relative humidity and minimum, maximum and daily
average temperature), from the Mexican government’s air monitoring stations. Concentrations of SO2 and NO2 were also
recorded but levels were low. In order to locate the nearest monitoring station, no further than 5 km away, each participating
child’s home was plotted on a map. Information on environmental
tobacco smoke exposure (ETS) was obtained from the baseline
questionnaire and included questions on smokers in the home
(mother, father, others) and number of cigarettes smoked per day
in the home and in the presence of the child.
Nasal lavage samples processing
Nasal lavage was obtained as described by Noah et al. [12] using
a disposable syringe filled with sterile, normal saline solution at
room temperature. This device was used five times in each
nostril while occluding the other nostril; then the subject was

instructed to exhale through the lavaged side into a specimen
cup and the returned fluid pooled. The total input of saline
solution was approximately 5 ml and the return was close to
40%. The lavage fluid was passed through filters to remove the
mucus and cell debris and frozen immediately and kept at
- 70∞C for mediator’s assays. None of the samples were contaminated with blood.

Cytokine analysis
Soluble components were normalized per ml of nasal lavage fluid.
IL-8 and IL-6 levels were measured using enzyme-linked immunosorbent assay (ELISA) kits purchased from R&D Systems
(Minneapolis, MN, USA). Total proteins and albumin levels were
determined using a centrifugal chemical analyser purchased from
Roche Laboratories COBAS-FARA, Branchburg (NJ, USA) at
the laboratory of Dr Robert Devlin, US EPA Human Studies
Division, NC, USA.
Biochemical analysis
Blood samples were collected in EDTA vacutainer tubes, covered immediately with aluminium foil and centrifuged to obtain
plasma. Aliquots were stored at - 70∞C and shipped on dry ice
to the laboratory of Dr Gary Hatch at the US EPA for analysis. a-Tocopherol (vitamin E) in the plasma was extracted for
lipids, then measured by high performance liquid chromatography (HPLC) with electrochemical detection using methods
described previously [13]. A second aliquot of plasma was
treated with 4% perchloric acid to a final concentration of 1%
then it was vortex centrifuged (27 000 g for 20 min). Supernatants were assayed for total glutathione (reduced plus oxidized) using a COBAS-FARA II clinical analyser (Roche
Diagnostics, Branchburg, NJ, USA) using the glutathione reductase recycling method [14].
In nasal lavage, total glutathione was determined using the
method already described. Urate and vitamin C were measured
on the perchloric acid treated nasal lavage, using HPLCelectrochemistry [15]. Vitamin C levels were mostly under the
detection limit, probably because of improper handling of the
sample, and therefore could not be studied.
Statistical analysis
We studied the effect of ozone exposure on the levels of IL-6 and
IL-8 in subjects assigned to receive a placebo or supplement as
well as on the levels of uric acid and GSx in nasal fluid. We used
the daily maximum of 8-h moving average as exposure to ozone as
well as cumulative exposure over several days prior to nasal lavage. Pearson correlation was determined between levels of air
contaminants and various climatic variables [16]. Comparisons of
cytokine and antioxidant levels in nasal lavage and blood were
performed on log-transformed data to normalize the distribution.
Levels at baseline, 6 weeks and 12 weeks were compared between
the placebo and supplement groups using t-test for independent
samples. In addition, we evaluated the change in levels within
each group comparing levels at baseline and at 12 weeks using the
paired t-test [16].
We analysed data using mixed effect models for longitudinal
data to determine the association between air pollutant exposure
and levels of inflammatory markers, defining each child as the
group variable. This type of model assumes that the relationship
between variables has the same structure for each individual but
allows the regression coefficients to vary. The model determines
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the conditional expected value of the response variable based on
individual characteristics [17]. We adjusted models for potential
confounding factors including participants’ age and exposure to
environmental tobacco smoke (ETS), atopy, temperature (mean
temperature), relative humidity, asthma severity, use of corticoids
and uric acid levels in nasal lavage. In the final models, we
adjusted only for age, asthma severity (mild or moderate and
severe), week of the study, total protein (to adjust for dilution),
use of corticoids and uric acid levels in the nasal lavage, because
the inclusion of other variables did not modify the results. We
compared regression coefficients using a t-test [16] to estimate the
effect of the supplementation and all analyses were conducted
using STATA software (version 7·0) [18]. Two participants did not
complete the follow-up because the mothers found visiting the
asthma clinic twice a week too inconvenient and were excluded
from the analysis.

RESULTS
Study population
Table 1 presents the characteristics of the population according to
the groups assigned either a placebo or a supplement. There was
no significant difference between the two groups except for atopy,
which was more frequent among children assigned to the placebo
group (95% in the placebo group and 81% in the supplement
group, P = 0·03). Skin tests showed positive results most frequently for dermatophagoides, cat and Blatella germanica.
At baseline participants’ mean reported dietary intakes of
vitamin C and vitamin E were 97·0 mg (SE = 2·0) and 5·1 mg
(SE = 1·6), respectively. Intake of these nutrients was similar in
the supplement and placebo groups.
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Exposure data
During the study period (from May 17, 1999 to April 19, 2000),
ozone 8-h moving average ranged from 11·1 to 142·5 p.p.b., with a
mean of 66·2 p.p.b. The maximum of PM10 8-h moving average
ranged from 16·6 mg/m3 to 180·9 mg/m3 with a mean of 77·3 mg/m3.
Ozone and PM10 were negatively related to minimum temperature (r = -0·17, P < 0·001; r = -0·28, P < 0·001, respectively).
Cytokine and antioxidant levels in the nasal fluids
At baseline, IL-6 and IL-8 were slightly higher in the supplement
group [mean (SE): 48·6 (23·4) versus 25·3 (10·5) pg/ml for IL-6,
P = 0·21 and 825·8 (140·8) versus 732·6 (131·6) pg/ml for IL-8,
P = 0·25], due probably to the higher proportion of children with
moderate and severe asthma in this group. Both IL-6 and IL-8
decreased in subsequent weeks in the placebo and supplement
groups. However, the only significant decrease between baseline
and 12 weeks was observed for IL-6 in the supplement group
[mean (SE): 48·6 (23·4) versus 11·4 (2·3) pg/ml P < 0·05]. Uric acid
also decreased in both groups, more so in the placebo group
(P < 0·01), while GSx increased significantly in both groups
(P < 0·01).
Blood data
At baseline plasma a-tocopherol levels were similar among the
placebo and supplement group [mean (SE): 3·02 (0·14) mg/ml in
the placebo group versus 3·02 (0·134) mg/ml in the supplement
group]. Plasma a-tocopherol levels were significantly higher in
the group receiving supplement than in the placebo group at
12 weeks follow-up [mean (SE): 2·97 (0·12) mg/ml in the placebo
group versus 4·14 (0·21) ng/ml in the supplement group,
P < 0·01].

Table 1. Characteristics of the study population; asthmatic children residing in Mexico City, 1998–2000

Characteristics
Gender (% male)
Age (years)
Time residing in Mexico City (years)
Age at asthma diagnosis (years)
Number of crises of asthma in the last 12 months
Asthma severity
Mild (%)
Moderate and severe (%)
Chronic cough in the last 12 months (%)
Wheezing in the last 12 months (%)*
Rhinitis (%)
Antibiotics use in last 12 months (%)
Use of inhaled medicine ever (%)
Smoking at home
Mother (%)
Father (%)
Others (%)
Atopy (%)
Animals at home (%)†
Dog (%)
Cat (%)
Birds (%)
Cockroach (%)†

Supplement (n = 59)

Placebo (n = 58)

P

64·4
8·9
8·6
3·3
2·6

63·8
9·2
8·7
3·1
2·5

0·94
0·52
0·77
0·50
0·49

47·5
52·5
82·8
52·6
38·9
57·9
91·2

58·6
41·4
69·0
46·2
43·1
42·1
80·7

0·23
0·23
0·16
0·61
0·65
0·11
0·11

22·8
48·2
19·0
81·0
58·6
46·6
5·2
17·2
15·8

15·5
43·6
21·0
94·6
50·9
38·6
12·3
15·8
25·0

0·32
0·63
0·79
0·03
0·41
0·39
0·18
0·84
0·22

*Twice or more during the year. †Proportion of homes for which parents reported having pets or pests.
© 2004 Blackwell Publishing Ltd, Clinical and Experimental Immunology, 138:317–322
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3-day lag‡
3-day cumulative§
IL-8
1-day lag
3-day lag
3-day cumulative

Beta† (SE)

P-value

Placebo
Supplement
Placebo
Supplement
Placebo
Supplement

0·98 (0·44)
-0·02 (0·42)
1·07 (0·30)
0·04 (0·31)
1·44 (0·47)
0·09 (0·52)

0·02
0·97
0·00
0·90
0·00
0·86

Placebo
Supplement
Placebo
Supplement
Placebo
Supplement

0. 80 (0·49)
-0·26 (0·49)
0·78 (0·37)
0·29 (0·38)
1·15 (0·55)
0·018 (0·62)

0·10
0·60
0·04
0·45
0·04
0·98

*Variables are log-transformed to improve normality. †The IL-6 models include 56 subjects and 112 observations in the placebo group and 57
subjects and 120 observations in the supplement group. The IL-8 models
include 58 subjects and 119 observations in the placebo group and 59
subjects and 126 observations in the supplement group. Adjusted for age,
week of the study, asthma severity, total protein content of nasal lavage,
uric acid content in nasal lavage and use of corticoids. Each beta coefficient
refers to the change in the IL-6 or IL-8 levels (ln-transformed) in nasal
lavage for an increased of 100 ppb of ozone (8-h moving average). The Pvalue refers to the significance of this change. The effect of supplementation is determined comparing the coefficients of the placebo and supplement groups (multiplied by 100) using t-test. Significance levels are:
‡P = 0·01; §0·01 < P = 0·05; ¶0·05 < P = 0·10.

IL-6
2·0
1·5

IL-8
placebo

IL-6
1-day lag¶

Subgroup

In this double-blind intervention study, we observed that children
who received placebo had a significant increase in IL-6 and IL-8
in nasal lavage in response to ozone exposure, while children
receiving antioxidant supplement did not. To our knowledge this
is the first study conducted in asthmatic children suggesting that
antioxidant supplementation might decrease the nasal inflammatory response to air pollutants as a marker of lower airway
inflammation.
Controlled human exposure and field studies have shown that
levels of ozone found in ambient air induced transient functional
and inflammatory changes in the lung, particularly in asthmatics
[4,19]. It is believed that the effects of ozone are mediated
through oxidant damage to cell structures [3,20,21] with a possible
role for oxidant-initiated activation of cell signalling processes.
Augmented production of ROS has been found in adults and children with very severe asthma and acute exacerbation of asthma
[7]. Recent studies examining the inflammatory response in bronchoalveolar lavage (BAL) fluid and bronchial wash have shown
that short-term exposure of mild atopic asthmatics to ozone,
induces polymorphonuclear leucocytes (PMNL) influx in the
lower airway, paralleled by the release of soluble mediators of
inflammation including albumin, total protein, myeloperoxidase
(MPO), lactate deshydrogenase and cytokines (including IL-8
and GM-CSF) and eosinophil cationic proteins [5–7,22,23].
Krishna et al. report an increase in IL-8 related to exposure to
200 ppb of ozone [22]. Similarly, Hiltermann reports an increase
in IL-8, as well as changes in eosinophils in sputum and BAL of
asthmatics after ozone exposure (0·4 ppm for 2 h) [5]. After

supplement

Variables*

DISCUSSION

supplement

Table 2. Change in IL-6, IL-8 (log-transformed) related to ozone
(100 ppb) concentrations with a 1 and 3 day lags and accumulated over
3 days prior to nasal lavage

in the 3-day mean of ozone (8-h moving average) the decrease in
GSx was –0·35 (95% CI –0·66 to –0·04) in the placebo group and
–0·33 (95% CI –0·60 to –0·06) in the supplement group. However,
we did not observe significant differences in the changes of GSx
between the placebo and supplement groups. Uric acid in nasal
lavage was negatively related to ozone levels in the placebo group
but changes were non significant (Table 3). These results
remained similar after adjustment for PM 10 ambient levels.

placebo

Inflammatory response to air pollutant exposure
Table 2 presents the results of the statistical analyses of IL-6 and
IL-8 and ozone concentrations (8-h moving average) on different
lags prior to the nasal lavage for the supplement and placebo
group. After adjustment for age, week of the study, use of corticoids, uric acid, total protein levels in nasal lavage and severity of
asthma, ozone levels were positively associated with IL-6 levels in
the placebo group, while no significant increase was observed in
the supplement group. An increase of 1·07 pg/ml [95% confidence
interval (CI) 0·48–1·65] was observed in the placebo group in relation with 100 ppb ozone exposure with a 3-day lag, while in the
supplement group there was no significant change (0·04 pg/ml,
95% CI - 0·56–0·64). The difference of the ozone effect on IL-6
levels between the two groups (placebo and supplement) was
highly significant for ozone exposure 3 days prior to the nasal lavage and when considering a cumulative exposure to ozone over
3 days (P = 0·02) (Fig. 1). For IL-8 levels, a significant increase
was observed in the placebo group with the maximum effect
3 days after exposure (P = 0·04) and when considering a cumulative exposure to ozone over 3 days (P = 0·04). No significant
change was observed in the supplement group. However, the difference in the ozone effect on IL-8 levels between the two groups
was not significant.
GSx in nasal lavage decreased in both groups in relation to
ozone exposure. Cumulative ozone exposure was related to a
larger depletion. When we estimated the impact of 3 consecutive
days of ozone exposure, we observed that for 100 ppb increment

Change by 100 ppb of ozone (in scale)
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1·0
0·5
0·0
–0·5
–1·0
1-day lag 3-day lag 3-day cum 1-day lag 3-day lag 3-day cum

Fig. 1. Change in IL-6 and IL-8 (ln scale) in nasal lavage related to
100 ppb ozone in the placebo and supplement groups of asthmatic children
with different lags prior to exposure. The significance of changes per group
are presented within the bars, and the significance of changes between
P £ 0·05
groups are presented on the upper part of the graph.
0·05 < P £ 0·10.
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Table 3. Change in GSx and uric acid (log-transformed) related to ozone
(100 ppb) concentrations with a 2-day lag and accumulated over 3 days
prior to nasal lavage

Variables*
GSx
2-day lag
3-day lag
3-day cumulative
Uric acid
2-day lag
3-day lag‡
3-day cumulative

Subgroup

Beta† (SE)

P-value

Placebo
Supplement
Placebo
Supplement
Placebo
Supplement

-0·13 (0·15)
-0·29 (0·13)
-0·27 (0·10)
-0·06 (0·09)
-0·35 (0·16)
-0·33 (0·14)

0·39
0·03
0·01
0·51
0·03
0·02

Placebo
Supplement
Placebo
Supplement
Placebo
Supplement

-0·25 (0·38)
0·08 (0·41)
-0·34 (0·27)
0·41 (0·28)
-0·42 (0·40)
0·34 (0·46)

0·51
0·85
0·20
0·14
0·30
0·46

*Variables are log-transformed to improve normality. †The model for
GSx includes 58 subjects and 159 observations in the placebo group and
59 subjects and 159 observations in the supplement group, adjusted for
week of the study, asthma severity, total protein content in nasal lavage,
and plasma GSx levels. The model for uric acid includes 59 subjects and
142 observations in the placebo group and 58 subjects and 143 observations in the supplement group. Adjusted for week of the study, asthma
severity, total protein content in nasal lavage. Each beta coefficient refers
to the change in the GSx or uric acid levels (ln transformed) in nasal lavage
for an increased of 100 ppb of ozone (8-h moving average). The P-value
refers to the significance of this change. The effect of supplementation is
determined comparing the coefficients of the placebo and supplement
groups (multiplied by 100) using a t-test. Significance levels are:
‡0·05 < P = 0·10.

repeated exposure to ozone, studies have suggested that the decrement in lung function observed after single exposure attenuated, suggesting an adaptation of lung function; however, the
airway inflammation persisted despite attenuation of some
inflammatory markers [6,23,24]. Jorres et al. reported that after
200 ppb of ozone exposure on 4 consecutive days, concentration
of total protein, IL-6 and IL-8, and GSx remained elevated while
the effect on lung function was abolished [23].
Both experimental and epidemiological studies have also suggested that antioxidant supplementation could modulate the
acute change in lung function observed among people exposed to
photo-oxidants [8,9]. We have shown recently among these children that antioxidant supplementation modulated the adverse
effect of ozone on lung function [10]. However, there are few data
on the impact of antioxidant supplementation on the production
of inflammatory mediators in asthmatic subjects and there is no
evidence of a relationship between the intensity of the inflammatory response and the functional decrement after exposure to
ozone [25].
To date, only one study has evaluated the impact of antioxidant supplementation on both functional and inflammatory
response. Samet et al. reported recently that antioxidant supplementation among healthy volunteers modulated the adverse
effect of ozone on pulmonary function and did not affect the
inflammatory response as represented by the percentage of neutrophils and the concentration of IL-6 [9]. Our population is not
directly comparable to that of Samet, given that it was composed
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of asthmatic children who were chronically exposed to high ozone
levels and were deficient in vitamin E [10]. Our results suggest
that in addition to modulating the adverse effect of ozone on lung
function [10], antioxidant supplementation could modulate the
inflammatory response, although the mechanisms by which antioxidants modulate the functional and inflammatory responses
may differ. Studies have shown that vitamin E supplementation
could decrease the production of inflammatory cytokines and
chemokines [26] and that other antioxidants, such as pyrrolidine
dithiocarbamate and N-acetyl-cysteine, could inhibit the secretion
of IL-8 after diesel exposure [27]. A recent animal study has also
shown that guinea pigs deficient in vitamin C and glutathione
were more susceptible to the effect of residual oil fly ash, with
unusual BAL cellular changes and lower antioxidants concentrations in BAL [28].
Decreases in uric acid and GSx have been observed after
ozone exposure, suggesting that it is consumed by ozone [29,30].
However, in some studies an adaptation of RTFL antioxidants is
observed including increases in GSx, uric acid from plasma RTLF
and mobilization of a-tocopherol from non-lung tissue to the
plasma [4]. In our study we observed a significant decreases of
GSx in both study groups with cumulative exposure being related
to a larger depletion. Unfortunately, we did not have information
on the ratio of reduced to oxidized glutathione (GSH/GSSG),
which would have provided more information relating to mechanisms. Uric acid in nasal lavage was negatively related to ozone
exposure in the placebo group; however, changes were nonsignificant. Because children in our study were chronically
exposed to high ozone levels and that the mechanism underpinning repletion capacity of the lining fluid of the upper airway are
not known [30], these results are difficult to interpret.
Several factors need to be considered in the interpretation of
our results. At baseline the characteristics of the two groups were
similar and by using a double-blinded intervention we were able
to avoid information bias. The exposure estimation of participating children was based on the monitoring network and not on personal measurement, possibly causing some misclassification of
exposure. This will tend to underestimate the potential protective
effect of antioxidant supplementation. We did not count with
information of allergens indoor and outdoors; however, for a
given child exposure to allergens is unlikely to vary with ozone
ambient levels and therefore would not confound the association.
Similarly, it is unlikely that ETS exposure be correlated with
ozone levels. In addition, accounting for ETS exposure and atopy
in the analysis did not affect our results.
We used nasal lavage to sample upper airway RTLF as it represented a relatively non-invasive procedure and has been proven
to be a reliable method to study acute inflammatory response to
inhaled pollutants [31] and reflect the acute inflammatory effect
of ozone in the lower lung [32]. At baseline, antioxidant intake
and plasma concentrations of vitamin E were similar in the supplement and placebo group. Participants reported intake of vitamin C close to the recommended dietary daily allowance (RDA);
however, vitamin E intake was lower than the RDA [30,33] compared to other populations, as observed in the serum [34]. During
this study, plasma vitamin E levels in the supplement group rose
by 37%, as in other supplementation studies [9,10], indicating that
participants were taking the supplement, of close to five times the
RDA, for vitamin C and vitamin E.
Our data suggest that vitamin C and vitamin E supplementation above the RDA in asthmatic children with a low intake of

© 2004 Blackwell Publishing Ltd, Clinical and Experimental Immunology, 138:317–322
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vitamin E provides some protection against the acute inflammatory response to ozone on their lungs, but the optimum dose still
needs to be determined.
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